Common Contracts
2 similar Preferred Stock Purchase Agreement contracts by Receptos, Inc.
OMNIBUS APPROVAL AND AMENDMENT WITH RESPECT TO: SERIES B PREFERRED STOCK PURCHASE AGREEMENT; AND THIRD AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENTPreferred Stock Purchase Agreement • April 4th, 2013 • Receptos, Inc. • Pharmaceutical preparations
This Omnibus Approval and Amendment (this “Amendment”) is made as of February 23, 2012, by and among RECEPTOS, INC., a Delaware corporation (the “Company”), the New Party (as defined below), and the stockholders of the Company tendering signature pages hereto with respect to the following: (i) that certain Series B Preferred Stock Purchase Agreement (the “Purchase Agreement”), made and entered into as of February 3, 2012, by and among the Company and the Purchasers (as defined in the Purchase Agreement); and (ii) that certain Third Amended and Restated Investors’ Rights Agreement (the “Investors’ Rights Agreement”), made and entered into as of February 3, 2012, by and among the Company and the Investors (as defined in the Investors’ Rights Agreement). This Amendment is made with reference to the following:
OMNIBUS APPROVAL AND AMENDMENT WITH RESPECT TO: SERIES B PREFERRED STOCK PURCHASE AGREEMENT; AND THIRD AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENTPreferred Stock Purchase Agreement • February 13th, 2013 • Receptos, Inc. • Pharmaceutical preparations
This Omnibus Approval and Amendment (this “Amendment”) is made as of February 23, 2012, by and among RECEPTOS, INC., a Delaware corporation (the “Company”), the New Party (as defined below), and the stockholders of the Company tendering signature pages hereto with respect to the following: (i) that certain Series B Preferred Stock Purchase Agreement (the “Purchase Agreement”), made and entered into as of February 3, 2012, by and among the Company and the Purchasers (as defined in the Purchase Agreement); and (ii) that certain Third Amended and Restated Investors’ Rights Agreement (the “Investors’ Rights Agreement”), made and entered into as of February 3, 2012, by and among the Company and the Investors (as defined in the Investors’ Rights Agreement). This Amendment is made with reference to the following:
